| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 4094304 | Seminars in Arthroplasty | 2007 | 8 Pages | 
Abstract
												Gene mutations leading to thrombophilia, hypofibrinolysis, and reduced nitric oxide production are risk factors for osteonecrosis. The importance of the diagnosis of thrombophilia-hypofibrinolysis in idiopathic osteonecrosis lies in the potential to stop the progression of osteonecrosis when enoxaparin is started at Ficat stages I or II before irreversible segmental collapse of the head of the femur.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Orthopedics, Sports Medicine and Rehabilitation
												
											Authors
												Charles J. MD, Richard A. MD, Ping PhD, 
											